✦ LIBER ✦

Paclitaxel (P) in combination with carboplatin (C) in the treatment of SCLC patients (a phase II study)

✍ Scribed by Zarogoulidis, K; Kontakiotis, T; Hatziapostolou, P; Tsianga, E; Papakosta, P; Goutsikas, J; Patakas, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Long-term survival in SCLC after treatme

✍ Reck, Martin; Jagos, Urzula; Grunwald, Franziska; Kaukel, Eckhard; Koschel, Gabr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

171 Paclitaxel (TAX) and carboplatin (CB

✍ Deppermann, K.M.; Kurzeja, A.; Lichey, J.; Serke, M.; Riedel, U.; Loddenkemper, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Phase I/II study of DHA–paclitaxel in co

✍ Harries, M; O'Donnell, A; Scurr, M; Reade, S; Cole, C; Judson, I; Greystoke, A; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

A phase I–II study with carboplatin (C)

✍ Fabi, A.; Barduagni, M.; De Marco, S.; De Marinis, F.; Cortesi, E.; Foggi, C.M.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 330 KB

A phase II study of combination paclitax

✍ W Yeo; T.W.T Leung; A.T.C Chan; S.K.W Chiu; P Yu; T.S.K Mok; P.J Johnson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB